Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD. This activity reviews the current applications, pharmacology, and toxicities of desipramine and highlights the role of the interprofessional team, improving care for patients on this medication.
